Made in GalChimia

Galchimia assisted to BioEurope Spring 2015 in Paris
March 19, 2015

We were happy to join and have a stand to this important meeting. Our stand was managed by Bioga, the Galician…

Read More
BioEurope 2015, March 8th to 11th, Paris (France)
March 18, 2015

Galchimia participated in BioEurope Spring 2015 in Paris. We were happy to join and have a stand to this important meeting….

Read More
R&D Work: One-pot Synthesis of Pyrazoles using Flow Chemistry
February 19, 2015

Preparation of Pyrazoles from Acetophenones in Flow using a 2–Stage Reaction Flow Chemistry is becoming more and more popular. We have…

Read More
Case Study: Custom Synthesis
February 9, 2015

In 2014 we were approached to prepare an intermediate in bulk. Our customer had specific issues finding suppliers for this product….

Read More
Case Study: Medicinal Chemistry
February 2, 2015

In 2012 we were asked to develop a Me-Better for a compound currently in Clinical Phase III. The product was developed…

Read More
2014 in Numbers
January 26, 2015

As is our tradition, here you have our figures about projects and products of 2014. Compiling this info takes only a…

Read More
GalChimia will be in Basel
December 4, 2014

GalChimia will be in Basel Area for 4 days in December To arrange a meeting during our instance, please contact Ms. Julie…

Read More
GalChimia will be in Belgium for a 3 days Business Trip and the MedChem 2014 day
November 19, 2014

GalChimia will be in Belgium 3 days next week and will attend MedChem 2014, this year the conference is about “New…

Read More
GalChimia has recently obtained the accreditation for Crédit d’Impôt Recherche (CIR)
November 12, 2014

Considered nowadays as the best tax incentive system for research in Europe, the CIR is a tax tool, that works as…

Read More
GalChimia licenses production process for two promising products: Eltrombopag Olamine and Prasugrel Hydrochloride
October 15, 2014

Over the years, GalChimia has become the leading synthetic organic chemistry CRO in Spain. Recently, the company decided to invest resources…

Read More